Dapsone Gel clinical trials
How each study uses Dapsone Gel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2010 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2016 | 1 |
| 2019 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 4
Almirall, S.A. (6) · Allergan (4) · Icahn School of Medicine at Mount Sinai (1) · Torrent Pharmaceuticals Limited (1) · Vanderbilt University Medical Center (1) · Assiut University (1) · Cook County Health (1)
Studies
Open first, then newest update. How each study uses Dapsone Gel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of ColorCompletedPhase 4Icahn School of Medicine at Mount SinaiNCT03681470Written as Aczone Gel
- DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARISStatus unknownPhase 4Assiut UniversityNCT05296460Written as Dapsone gel
- Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedPhase 3Torrent Pharmaceuticals LimitedNCT04015375Written as Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)
- Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne VulgarisCompletedPhase 4Almirall, S.A.NCT02959970Written as dapsone gel
- Safety and Efficacy Study of Dapsone Gel in Patients With Acne VulgarisCompletedPhase 3Almirall, S.A.NCT01974323Written as Dapsone Gel
- A Safety and Efficacy Study of Dapsone Gel in Patients With Acne VulgarisCompletedPhase 3Almirall, S.A.NCT01974141Written as Dapsone Gel
- Dermal Tolerability of Dapsone Gel in Healthy VolunteersCompletedPhase 1Almirall, S.A.NCT02117752Written as dapsone gel
- Photoallergy Potential of Dapsone Gel in Healthy VolunteersCompletedPhase 1Almirall, S.A.NCT02117739Written as dapsone gel
- Phototoxicity Test of Dapsone Gel in Healthy VolunteersCompletedPhase 1Almirall, S.A.NCT02108483Written as dapsone gel
- Use of Dapsone Gel, 5% for Treating Dermatitis HerpetiformisTerminatedPhase 4Vanderbilt University Medical CenterNCT01115244Written as Dapsone gel, 5%
- A Study of Dapsone Gel in Females With Skin of Color and Acne VulgarisCompletedPhase 4AllerganNCT02032407Written as Dapsone Gel
- Dapsone Prurigo StudyStatus unknownNot applicableCook County HealthNCT01870050Written as Dapsone gel - verum
- A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.CompletedPhase 2AllerganNCT00249782Written as ACZONE (dapsone) Gel, 5%, 2x/day
- Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD DeficiencyCompletedPhase 4AllerganNCT00243542Written as ACZONE Gel, 5%
- A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related RashTerminatedPhase 2AllerganNCT00343187Written as ACZONE (dapsone) Gel, 5%
As the comparator · 2 — what is tested is compared with Dapsone Gel
- Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne MedicationsCompletedPhase 4Stiefel, a GSK CompanyNCT00964366Written as Dapsone gel
- Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedPhase 1Taro Pharmaceuticals USANCT02929719Written as Aczone Gel 5%